Published in Am Rev Respir Dis on October 01, 1991
AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease. Thorax (1992) 1.72
AIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals. Thorax (1995) 1.26
Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986-7 and 1990-1. Thorax (1993) 1.18
Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol (1998) 1.03
Community acquired lobar pneumonia in patients with HIV infection and AIDS. Thorax (1994) 0.89
Effect of bacterial pneumonia on lung simian immunodeficiency virus (SIV) replication in alcohol consuming SIV-infected rhesus macaques. Alcohol Clin Exp Res (2013) 0.86
Chronic alcohol abuse and HIV disease progression: studies with the non-human primate model. Curr HIV Res (2014) 0.84
Comparison of community-acquired pneumonia requiring admission to hospital in HIV-and non-HIV-infected patients. Can J Infect Dis (1996) 0.78
Pulmonary complications of HIV disease. Thorax (1993) 0.75
High Resolution Computed Tomography Lung Spectrum in Symptomatic Adult HIV-Positive Patients in South-East Asian Nation. J Clin Diagn Res (2014) 0.75
Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet (1996) 4.22
Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis (1991) 3.79
Evaluation of the MB/BacT system and comparison to the BACTEC 460 system and solid media for isolation of mycobacteria from clinical specimens. J Clin Microbiol (1997) 3.10
Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis (1988) 3.09
Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med (1996) 2.85
Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis (1987) 2.71
Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg (1994) 2.68
Physiological changes in respiratory function associated with ageing. Eur Respir J (1999) 2.59
Comparison of recovery of organisms from blood cultures diluted 10% (volume/volume) and 20% (volume/volume). J Clin Microbiol (1982) 2.42
Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial. JAMA (1991) 2.32
Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med (2001) 2.23
Role of oxygen free radicals in cancer development. Eur J Cancer (1996) 2.20
Risk factors for a medically inappropriate admission to a Department of Internal Medicine. Arch Intern Med (1997) 2.19
Two different 16S rRNA genes in a mycobacterial strain. J Clin Microbiol (1996) 2.17
Prospective evaluation of patients with syncope: a population-based study. Am J Med (2001) 2.09
Evaluation of the new improved BHI-lysis blood culture medium for the BCB Roche system. Eur J Clin Microbiol Infect Dis (1991) 2.04
Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis (1983) 2.00
Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1999) 1.92
Radioautographic demonstration of 5-hydroxytryptamine- 3 H uptake by pulmonary endothelial cells. J Cell Biol (1972) 1.91
Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis (1991) 1.89
Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol (1998) 1.85
Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect (2000) 1.79
Mycobacterium canettii, the smooth variant of M. tuberculosis, isolated from a Swiss patient exposed in Africa. Emerg Infect Dis (1999) 1.79
European multicentre evaluation of a commercial system for identification of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1996) 1.79
European union standards for tuberculosis care. Eur Respir J (2012) 1.73
In-vitro activity of newer quinolones against aerobic bacteria. J Antimicrob Chemother (1986) 1.71
Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: role of a hospital information system. Infect Control Hosp Epidemiol (1996) 1.71
Clinical pharmacokinetics of the third generation cephalosporins. Clin Pharmacokinet (1985) 1.70
IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest (1995) 1.69
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1990) 1.68
Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2000) 1.67
A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med (1990) 1.63
Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis. Antimicrob Agents Chemother (1987) 1.62
Evaluation of the Wellcolex Colour Salmonella Test for detection of Salmonella spp. in enrichment broths. J Clin Microbiol (1992) 1.58
Predicting bacteremia in older patients. J Am Geriatr Soc (1995) 1.57
Uptake, metabolism and efflux of 14 C-5-hydroxytryptamine in isolated perfused rat lungs. J Pharmacol Exp Ther (1972) 1.53
Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus. Eur Respir J (2008) 1.52
Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost (2000) 1.45
Detecting acute thoracic aortic dissection in the emergency department: time constraints and choice of the optimal diagnostic test. Ann Emerg Med (1996) 1.42
Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation. Chest (1999) 1.41
Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci. Antimicrob Agents Chemother (1982) 1.41
Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med (1996) 1.40
Improvement of drug-induced chronic renal failure in lung transplantation. Transplantation (1999) 1.39
Human lung dendritic cells have an immature phenotype with efficient mannose receptors. Am J Respir Cell Mol Biol (1999) 1.35
Assessment of use of the COBAS AMPLICOR system with BACTEC 12B cultures for rapid detection of frequently identified mycobacteria. J Clin Microbiol (1999) 1.32
Combination therapy: a way to limit emergence of resistance? Am J Med (1986) 1.30
Concentration of (+/-)-propranolol in isolated, perfused lungs of rat. Br J Pharmacol (1976) 1.29
Comparison of immunological methods for diagnosis of pneumococcal pneumonia in biological fluids. Eur J Clin Microbiol (1987) 1.25
Accumulation of 14 C-imipramine in isolated perfused rat lungs. J Pharmacol Exp Ther (1972) 1.23
Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis (2001) 1.22
Site and mechanism of uptake of 3H--norepinephrine by isolated perfused rat lungs. Circ Res (1974) 1.20
Characterization of glycopeptide-resistant enterococci from a Swiss hospital. J Clin Microbiol (1998) 1.18
Comparison of BacT/Alert with Signal blood culture system. J Clin Microbiol (1995) 1.17
Molecular basis for cross-reactivity between a strain of Mycobacterium terrae and DNA probes for Mycobacterium tuberculosis complex. Eur J Clin Microbiol Infect Dis (1995) 1.16
International collaborative evaluation of the ATB 32 staph gallery for identification of the Staphylococcus species. Zentralbl Bakteriol (1990) 1.14
Metabolism and uptake of adenosine triphosphate and adenosine by porcine aortic and pulmonary endothelial cells and fibroblasts in culture. Circ Res (1978) 1.13
Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med (1989) 1.12
Evaluation of the Bactec 960 automated nonradiometric system for isolation of mycobacteria from clinical specimens. Eur J Clin Microbiol Infect Dis (2000) 1.10
Contour-clamped homogeneous electric field gel electrophoresis as a powerful epidemiologic tool in yeast infections. Am J Med (1991) 1.05
Predictors of inappropriate hospital days in a department of internal medicine. Int J Epidemiol (1998) 1.05
[Disseminated infection with Mycobacterium celatum]. Schweiz Med Wochenschr (1996) 1.03
Chronic destructive lung disease associated with a novel mycobacterium. Am J Respir Crit Care Med (1994) 1.03
Natural killer cell function in human lung is compartmentalized. Am Rev Respir Dis (1987) 1.02
Rapid diagnosis of gram negative pneumonia by assay of endotoxin in bronchoalveolar lavage fluid. Thorax (1992) 1.02
Matrix metalloproteinases correlate with alveolar-capillary permeability alteration in lung ischemia-reperfusion injury. Transplantation (2000) 1.02
Interleukin-12 production by human alveolar macrophages is controlled by the autocrine production of interleukin-10. Am J Respir Cell Mol Biol (1999) 1.00
Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1996) 0.99
GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. Am J Respir Crit Care Med (1995) 0.97
Variable glutathione levels and expression of antioxidant enzymes in human endothelial cells. Am J Physiol (1993) 0.97
Comparative evaluation of BACTEC aerobic Plus/F and Septi-Chek Release blood culture media. J Clin Microbiol (1996) 0.97
PGA1 and PGF2 alpha metabolism by pig pulmonary endothelium, smooth muscle, and fibroblasts. J Appl Physiol Respir Environ Exerc Physiol (1979) 0.96
Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J (1997) 0.96
Etiological agents of infectious diarrhea: implications for requests for microbial culture. J Clin Microbiol (1997) 0.95
Osteoporosis in patients undergoing lung transplantation. Eur Respir J (1996) 0.95
Molecular epidemiology of predominant clones and sporadic strains of methicillin resistant Staphylococcus aureus in Switzerland and comparison with European epidemic clones. Clin Microbiol Infect (2002) 0.95
Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species. Antimicrob Agents Chemother (1989) 0.95
Susceptibility testing of Haemophilus influenzae--an international collaborative study in quality assessment. J Antimicrob Chemother (1996) 0.95
Genetic background of attenuated Salmonella typhimurium has profound influence on infection and cytokine patterns in human dendritic cells. J Leukoc Biol (2001) 0.94
Costovertebral joint dysfunction: another misdiagnosed cause of atypical chest pain. Postgrad Med J (1992) 0.94
Amine uptake and metabolism by endothelium of pig pulmonary artery and aorta. Am J Physiol (1977) 0.94
Response of human endothelial cell antioxidant enzymes to hyperoxia. Am J Respir Cell Mol Biol (1992) 0.93
Evaluation of phagocytic activity in human monocyte-derived dendritic cells. J Aerosol Med (2001) 0.93
In vitro activity of a new semisynthetic cephalosporin: cefoperazone. Clin Ther (1980) 0.93
Metabolism, production, and release of hormones and mediators in the lung. Am Rev Respir Dis (1975) 0.92
Reactive oxygen metabolites increase mitochondrial calcium in endothelial cells: implication of the Ca2+/Na+ exchanger. J Cell Sci (1999) 0.92
Protein synthesis in hyperoxic endothelial cells: evidence for translational defect. J Appl Physiol (1985) (1987) 0.92
Characterization of a specific 20- to 25-kD interleukin-1 inhibitor from cultured human lung macrophages. Am J Respir Cell Mol Biol (1990) 0.91
Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. Eur J Clin Microbiol Infect Dis (2001) 0.90
Differential expression of hsp70 stress proteins in human endothelial cells exposed to heat shock and hydrogen peroxide. Am J Respir Cell Mol Biol (1991) 0.90
TSLP promotes influenza-specific CD8+ T-cell responses by augmenting local inflammatory dendritic cell function. Mucosal Immunol (2012) 0.90
FDG-PET in diagnostic work-up of pulmonary artery sarcomas. Eur Respir J (2010) 0.90
[Inter- and intrahospital transmission of methicillin-resistant Staphylococcus aureus]. Schweiz Med Wochenschr (1997) 0.89
Differential regulation of tumor necrosing factor-alpha (TNF-alpha) and interleukin-10 (IL-10) secretion by protein kinase and phosphatase inhibitors in human alveolar macrophages. Eur Cytokine Netw (1999) 0.89
Advantage of combining resin with lytic BACTEC blood culture media. J Clin Microbiol (1997) 0.89
Fibroblast-alveolar cell interactions in sarcoidosis and idiopathic pulmonary fibrosis: evidence for stimulatory and inhibitory cytokine production by alveolar cells. Eur Respir J (1990) 0.89
Regulation of interleukin-1ra, interleukin-1 alpha, and interleukin-1 beta production by human alveolar macrophages with phorbol myristate acetate, lipopolysaccharide, and interleukin-4. Am J Respir Cell Mol Biol (1993) 0.89
Has the diagnosis of pulmonary embolism become easier to establish? Respir Med (1995) 0.89
Human lung tissue macrophages, but not alveolar macrophages, express matrix metalloproteinases after direct contact with activated T lymphocytes. Am J Respir Cell Mol Biol (2001) 0.88
Differential effects of superoxide, hydrogen peroxide, and hydroxyl radical on intracellular calcium in human endothelial cells. J Cell Physiol (1995) 0.88